Aarey Drugs & Pharmaceuticals Gestion
Gestion contrôle des critères 4/4
Aarey Drugs & Pharmaceuticals' CEO is Mihir Ghatalia, appointed in Dec 2009, has a tenure of 14.92 years. total yearly compensation is ₹1.06M, comprised of 56.9% salary and 43.1% bonuses, including company stock and options. directly owns 16.49% of the company’s shares, worth ₹299.21M. The average tenure of the management team and the board of directors is 4.8 years and 4.6 years respectively.
Informations clés
Mihir Ghatalia
Directeur général
₹1.1m
Rémunération totale
Pourcentage du salaire du PDG | 56.9% |
Durée du mandat du directeur général | 14.9yrs |
Propriété du PDG | 16.5% |
Durée moyenne d'occupation des postes de direction | 4.8yrs |
Durée moyenne du mandat des membres du conseil d'administration | 4.6yrs |
Mises à jour récentes de la gestion
Recent updates
Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2024 | n/a | n/a | ₹52m |
Mar 31 2024 | ₹1m | ₹600k | ₹47m |
Dec 31 2023 | n/a | n/a | ₹29m |
Sep 30 2023 | n/a | n/a | ₹24m |
Jun 30 2023 | n/a | n/a | ₹37m |
Mar 31 2023 | ₹1m | ₹600k | ₹38m |
Dec 31 2022 | n/a | n/a | ₹27m |
Sep 30 2022 | n/a | n/a | ₹41m |
Jun 30 2022 | n/a | n/a | ₹48m |
Mar 31 2022 | ₹2m | ₹600k | ₹66m |
Dec 31 2021 | n/a | n/a | ₹87m |
Sep 30 2021 | n/a | n/a | ₹85m |
Jun 30 2021 | n/a | n/a | ₹77m |
Mar 31 2021 | ₹1m | ₹602k | ₹65m |
Dec 31 2020 | n/a | n/a | ₹61m |
Sep 30 2020 | n/a | n/a | ₹58m |
Jun 30 2020 | n/a | n/a | ₹51m |
Mar 31 2020 | ₹1m | ₹600k | ₹58m |
Dec 31 2019 | n/a | n/a | ₹55m |
Sep 30 2019 | n/a | n/a | ₹57m |
Jun 30 2019 | n/a | n/a | ₹65m |
Mar 31 2019 | ₹2m | ₹600k | ₹65m |
Dec 31 2018 | n/a | n/a | ₹66m |
Sep 30 2018 | n/a | n/a | ₹69m |
Jun 30 2018 | n/a | n/a | ₹64m |
Mar 31 2018 | ₹300k | ₹300k | ₹62m |
Rémunération vs marché: Mihir's total compensation ($USD12.55K) is below average for companies of similar size in the Indian market ($USD42.81K).
Rémunération et revenus: Mihir's compensation has been consistent with company performance over the past year.
PDG
Mihir Ghatalia (41 yo)
14.9yrs
Titularisation
₹1,055,262
Compensation
Mr. Mihir Rajesh Ghatalia, B.E., serves as an Executive Director at Worth Investment & Trading Company Limited. He has been the Managing Director at Aarey Drugs & Pharmaceuticals Ltd. since December 29, 20...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chairman & MD | 14.9yrs | ₹1.06m | 16.49% ₹ 299.2m | |
Executive Director | 4.3yrs | ₹758.07k | pas de données | |
Chief Financial Officer | 3.8yrs | pas de données | pas de données | |
Chief Accountant | 26.8yrs | pas de données | pas de données | |
Company Secretary & Compliance Officer | 4.8yrs | ₹429.23k | pas de données |
4.8yrs
Durée moyenne de l'emploi
41yo
Âge moyen
Gestion expérimentée: 524412's management team is considered experienced (4.8 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Chairman & MD | 20.3yrs | ₹1.06m | 16.49% ₹ 299.2m | |
Executive Director | 4.3yrs | ₹758.07k | pas de données | |
Non-Executive Independent Director | 4.8yrs | pas de données | 0.0030% ₹ 53.7k | |
Non Independent Non-Executive Woman Director | 1.1yrs | pas de données | 14.12% ₹ 256.2m | |
Non-Executive Independent Director | 16.4yrs | pas de données | 1.06% ₹ 19.2m | |
Independent Non Executive Director | 4.3yrs | pas de données | pas de données |
4.6yrs
Durée moyenne de l'emploi
48.5yo
Âge moyen
Conseil d'administration expérimenté: 524412's board of directors are considered experienced (4.6 years average tenure).